Table 2. RIP3 immunohistochemical data for lung adeno-NSCLC: association of RIPK3 score with clinical characteristics.
Clinical factors | RIPK3 | P value | |
---|---|---|---|
High (n=53) | Low (n=90) | ||
Age | 0.794 | ||
≤65 | 31 | 55 | |
>65 | 22 | 35 | |
Sex | 0.096 | ||
Female | 17 | 43 | |
Male | 36 | 47 | |
Smoking Hx | 0.375 | ||
Current | 16 | 18 | |
Former | 8 | 17 | |
Never | 29 | 55 | |
TNM stage | 0.370 | ||
Ia | 21 | 35 | |
Ib | 14 | 15 | |
IIa | 5 | 13 | |
IIb | 5 | 4 | |
IIIa | 3 | 13 | |
IV | 5 | 10 |
NSCLC, non-small cell lung cancer.